Our analysis demonstrated that in LCC, age above 61 years, stage II–III disease, and chromogranin A positivity were independent adverse prognostic factors for overall survival, whereas CD56 expression was associated with shorter disease-free survival. This evidence concerns the gene NCAM1 and leukoencephalopathy with calcifications and cysts.